← All news

TürkiyeResearch and clinical trials

10 years of Trisomy 18 and 13 data in Istanbul: some children lived longer

Peer-reviewed publication

A study published in a journal and reviewed by independent scientists. Even so, a single study is not conclusive; it needs to be replicated.

Istanbul's Zeynep Kamil Hospital retrospectively reviewed ten years of records. A total of 29 children diagnosed by genetic testing were included in the study. Of these, 23 had Trisomy 18 and 6 had Trisomy 13. The most common problem was in the heart. Most children survived the first months, but losses increased afterward. A small number of children lived longer.

What does it mean for patients and families?

In this disease, the course can vary from child to child. Care decisions should be made together with the family, based on the child. Protection against infection is very important.

Source

PubMed (Children (Basel)): Trisomy 18 and Trisomy 13: A Retrospective Cohort Study at a Tertiary Hospital.

Scientific paper: Trisomy 18 and Trisomy 13: A Retrospective Cohort Study at a Tertiary Hospital. Children, 2026. DOI: 10.3390/children13020271 · PubMed 41749627

The source page was opened and read on October 7, 2026. Summary prepared by the Doktorclub editorial team and translated from Turkish; it has not yet been reviewed by a physician (a scientific board is being set up).

This page is translated from the Turkish original.

This page reports a development; it is not a treatment recommendation. Your doctor decides whether a treatment is right for you.

The information on these pages is for general information only and does not replace medical advice. Talk to your doctor about diagnosis and treatment decisions. In an emergency in Türkiye, call 112.

Every update is based on an open source and labeled with its level of evidence. No advertising and no drug brand names. Our scientific principles

This page was translated from Turkish by the Doktorclub editorial team.